The Impact of Molecular Diagnostic Tests on Patient Outcomes

This publication has 43 references indexed in Scilit:

• Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers:: Causative factors affecting sensitivity and specificity
  Urologic Oncology: Seminars and Original Investigations, 1997
• Detectable Molecular Residual Disease at the Beginning of Maintenance Therapy Indicates Poor Outcome in Children With T-Cell Acute Lymphoblastic Leukemia
  Blood, 1997
• Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer
  JAMA, 1997
• The Genetics of Ovarian Cancer: An Assessment of Current Screening Protocols and Recommendations for Counseling Families at Risk
  Clinical Obstetrics and Gynecology, 1996
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis
  Nature Genetics, 1996
• The genetic attributable risk of breast and ovarian cancer
  Cancer, 1996
• Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Polymerase Chain Reaction-Based K-rasMutation Detection of Pancreatic Adenocarcinoma in Routine Cytology Smears
  American Journal of Clinical Pathology, 1996
• Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction
  The Lancet, 1994
• Two Patients with Cystic Fibrosis, Nonsense Mutations in Each Cystic Fibrosis Gene, and Mild Pulmonary Disease
  New England Journal of Medicine, 1990